RELMADA THERAPEUTICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
RELMADA THERAPEUTICS, INC. (RLMD) had Deferred Tax Assets, Operating Loss Carryforwards of $6.20 million as of 2017-12-22, per its 8-K filed 2019-10-18.
Discontinued › Notes › Income Taxes › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2019-10-18
- 2017-12-22: Deferred Tax Assets, Operating Loss Carryforwards $6.20M.
- 2016-06-30: Deferred Tax Assets, Operating Loss Carryforwards $13.38M.
- 2015-06-30: Deferred Tax Assets, Operating Loss Carryforwards $9.82M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $8.26M.
- 2014-06-30: Deferred Tax Assets, Operating Loss Carryforwards $3.56M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2017-12-22 | $6.20M 8-K · filed 2019-10-18 | |
| 2016-06-30 | $13.38M 10-K · filed 2016-09-09 | |
| 2015-06-30 | $9.82M 10-K · filed 2016-09-09 | $8.26M 10-K · filed 2015-09-11 |
| 2014-06-30 | $3.56M 10-K · filed 2015-09-11 | |
| 2013-12-31 | $2.77M 10-KT · filed 2014-09-09 | |
| 2013-08-31 | $48.02K 10-K · filed 2013-12-16 | |
| 2012-12-31 | $1.76M 8-K · filed 2014-05-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |